AnalystsMike MatsonMike Matson's Stock Forecasts
AnalystsMike Matson
Analyst Ranking
Bottom 4%
#4715 out of 4870 analysts
Average Return
-1.93%
Win Rate
41%179 out of 432
Risk vs Reward
Poor
Good
Mike Matson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Personalis IncPSNL | +269.23% | $1.17 | $4.32 | 2023-11-08 - 2024-11-07 | Buy |
Personalis IncPSNL | +216.39% | $1.22 | $3.86 | 2024-06-21 - 2025-05-01 | Buy |
Personalis IncPSNL | +210.28% | $2.14 | $6.64 | 2024-01-05 - 2025-01-03 | Buy |
Personalis IncPSNL | +173.55% | $1.55 | $4.24 | 2024-02-29 - 2025-02-27 | Buy |
Cantel Medical CorpCMD | +158.06% | $31.93 | $82.40 | 2020-05-12 - 2021-01-13 | Buy |
Mike Matson Analyst Color
Get additional color on Mike Matson's coverage of popular stocks
Mike Matson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Conmed CorpCNMD | 23 | Buy | $61.00 | +6.66% | Maintains | 21 hours ago |
Atricure IncATRC | 30 | Buy | $44.00 | +50.22% | Maintains | 2 days ago |
Neogenomics IncNEO | 24 | Buy | $8.50 | +17.08% | Maintains | 3 days ago |
Merit Medical Systems IncMMSI | 26 | Buy | $100.00 | +7.30% | Maintains | 7 days ago |
Boston Scientific CorpBSX | 23 | Buy | $115.00 | +11.44% | Maintains | 8 days ago |
Lucid Diagnostics IncLUCD | 18 | Buy | $3.00 | +132.56% | Reiterates | 21 days ago |
Personalis IncPSNL | 20 | Buy | $7.00 | +81.35% | Reiterates | 22 days ago |
Orthopediatrics CorpKIDS | 19 | Buy | $42.00 | +100.67% | Reiterates | 23 days ago |
Enovis CorpENOV | 14 | Buy | $64.00 | +84.97% | Reiterates | 23 days ago |
Oncocyte CorpOCX | 17 | Buy | $4.25 | +37.10% | Reiterates | 24 days ago |
Stryker CorpSYK | 7 | Buy | $442.00 | +18.18% | Reiterates | a month ago |
Haemonetics CorpHAE | 10 | Buy | $104.00 | +65.11% | Maintains | a month ago |
Livanova PLCLIVN | 25 | Buy | $64.00 | +73.96% | Reiterates | a month ago |
Artivion IncAORT | 21 | Buy | $32.00 | +37.16% | Maintains | 2 months ago |
Veracyte IncVCYT | 16 | Buy | $51.00 | +71.66% | Reiterates | 2 months ago |
Hologic IncHOLX | 15 | Hold | $90.00 | +57.12% | Downgrades | 3 months ago |
Paragon 28 IncFNA | 16 | Hold | $13.00 | -0.69% | Downgrades | 3 months ago |
Transmedics Group IncTMDX | 4 | Hold | $109.00 | +20.51% | Downgrades | 5 months ago |
Resmed IncRMD | 10 | Hold | $236.00 | -0.21% | Downgrades | 8 months ago |
Surmodics IncSRDX | 14 | Buy | $43.00 | N/A | Maintains | a year ago |
Inari Medical IncNARI | 4 | Buy | $57.00 | N/A | Maintains | a year ago |
Shockwave Medical IncSWAV | 6 | Buy | $286.00 | N/A | Maintains | a year ago |
Masimo CorpMASI | 12 | Buy | $86.00 | N/A | Maintains | a year ago |
Axonics IncAXNX | 15 | Buy | $63.00 | N/A | Maintains | 2 years ago |
Inogen IncINGN | 7 | Buy | $26.00 | N/A | Reiterates | 2 years ago |
Teleflex IncTFX | 4 | Buy | $291.00 | N/A | Reiterates | 2 years ago |
Penumbra IncPEN | 4 | Buy | $300.00 | N/A | Maintains | 2 years ago |
Inmode LtdINMD | 8 | Buy | $60.00 | N/A | Reiterates | 2 years ago |
Steris PLCSTE | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Medtronic PLCMDT | 7 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zimmer Biomet Holdings IncZBH | 15 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cardiovascular Systems IncCSII | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Invacare CorpIVCRQ | 1 | Buy | $8.00 | N/A | Maintains | 4 years ago |
Genmark Diagnostics IncGNMK | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Si Bone IncSIBN | 1 | Buy | $34.00 | N/A | Maintains | 4 years ago |
Globus Medical IncGMED | 1 | Buy | $75.00 | N/A | Maintains | 4 years ago |
Cantel Medical CorpCMD | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Hill Rom Holdings IncHRC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nuvasive IncNUVA | 1 | Buy | $74.00 | N/A | Upgrades | 5 years ago |
Wright Medical Group NvWMGI | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.